Ac-Tyr Thr Ser Leu Ile His Ser Leu Ile Glu Glu Ser Gln Asn Gln Gln Glu Lys Asn Glu Gln Glu Leu Leu Glu Leu Asp Lys Trp Ala Ser Leu Trp Asn Trp Phe-NH2
Type
Peptide
Class
Antiviral
DG03107 Anti-HIV agent
Remark
ATC code:
J05AX07
Product:
D02499<US>
Efficacy
Antiviral, HIV-1 gp41 fusion inhibitor
Disease
HIV-1 infection [DS:H01563]
Target
HIV-1 gp41 [KO:K24801]
Pathway
ko03230
Viral genome structure
ko03250
Viral life cycle - HIV-1
Interaction
Structure map
map07053
Anti-HIV agents
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05A DIRECT ACTING ANTIVIRALS
J05AX Other antivirals
J05AX07 Enfuvirtide
D02499 Enfuvirtide (USAN/INN) <US>
USP drug classification [BR:br08302]
Antivirals
Anti-HIV Agents, Other
Enfuvirtide
D02499 Enfuvirtide (USAN/INN)
Drug groups [BR:br08330]
Antiviral
DG03107 Anti-HIV agent
D02499 Enfuvirtide
Drug classes [BR:br08332]
Antiviral
DG03107 Anti-HIV agent
D02499 Enfuvirtide
Antimicrobials [BR:br08307]
Antivirals
Entry, fusion or uncoating inhibitor
HIV gp41/gp120
D02499 Enfuvirtide (USAN/INN) <US>
Antimicrobials abbreviations [BR:br08327]
Antivirals
Entry, fusion or uncoating inhibitor
HIV gp41/gp120
D02499 Enfuvirtide (USAN/INN)
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D02499
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D02499
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D02499